首页 | 本学科首页   官方微博 | 高级检索  
     

PI3K/AKT信号通路在急性白血病中调控机制的初步研究
引用本文:Wang WL,Zhang YC,Zeng HM,Hua CL,Wei W,Xu J,Zhu XF,Cheng T,Yuan WP. PI3K/AKT信号通路在急性白血病中调控机制的初步研究[J]. 中国实验血液学杂志, 2012, 20(1): 18-21
作者姓名:Wang WL  Zhang YC  Zeng HM  Hua CL  Wei W  Xu J  Zhu XF  Cheng T  Yuan WP
作者单位:中国医学科学院北京协和医学院血液学研究所血液病医院实验血液学国家重点实验室
基金项目:国家自然科学基金资助项目(编号81070390),国家自然科学基金资助项目(编号81090414);国家973项目(编号2011CB964801)
摘    要:本研究探讨PI3K/AKT通路中的PTEN、CCND1、mTOR、RICTOR、FOXO1基因在急性髓系白血病(AML)、急性淋巴细胞白血病(ALL)患者中与正常人中表达的差异,以期查明PI3K/AKT通路在白血病中是否存在通路失调。随机收集16例骨髓标本,其中白血病12例(AML 6例,ALL 6例),正常骨髓标本4例。用实时定量RT-PCR方法检测PI3K/AKT通路中的PTEN、CCND1、mTOR、RICTOR、FOXO1基因的表达变化;以管家基因GAPDH为内参,按2-△△Ct法计算目的基因相对表达量。结果表明:PTEN、mTOR、RICTOR在AML、ALL中总体呈低表达趋势,PTEN在12例标本中有10例低表达,mTOR在12例标本中9例低表达,RICTOR在12例标本中7例低表达;FOXO1,CCND1在AML、ALL中则呈高表达趋势,FOXO1在12例标本中有9例高表达,CCND1在12例标本中7例高表达。结论:PI3K/AKT信号通路基因在白血病细胞中被激活。

关 键 词:PI3K/AKT  AML  ALL  白血病

Regulatory mechanisms of PI3K/AKT signaling pathway in acute leukemia
Wang Wei-Li,Zhang Ying-Chi,Zeng Hui-Min,Hua Chun-Lan,Wei Wei,Xu Jin,Zhu Xiao-Fan,Cheng Tao,Yuan Wei-Ping. Regulatory mechanisms of PI3K/AKT signaling pathway in acute leukemia[J]. Journal of experimental hematology, 2012, 20(1): 18-21
Authors:Wang Wei-Li  Zhang Ying-Chi  Zeng Hui-Min  Hua Chun-Lan  Wei Wei  Xu Jin  Zhu Xiao-Fan  Cheng Tao  Yuan Wei-Ping
Affiliation:Chinese Academy of Medical Sciences, Tianjin, China.
Abstract:This study was aimed to analyze the expression profiles of PI3K/AKT signaling pathway genes from bone marrow samples of AML and ALL patients and normal samples. AML, ALL and normal bone marrow samples were collected from 6 AML, 6 ALL patients and 4 normal persons. The expression of PI3K/AKT signaling pathway genes including PTEN, CCND1, mTOR, RICTOR, FOXO1 were detected by real-time fluorescent quantification RT-PCR while GAPDH gene expression was used as an internal reference. The relative gene expression level was calculated by the method of the 2(-ΔΔCt). The results showed that the gene expression profiles were different between normal and leukemic groups. PTEN, mTOR and RICTOR expression levels were down-regulated, while FOXO1 and CCND1 levels were up-regulated in AML and ALL. PTEN was down-regulated in 10 out of the 12 samples; mTOR was down-regulated in 9 out of the 12 samples; RICTOR was down-regulated in 7 out of the 12 samples; FOXO1 was up-regulated in 9 out of the 12 samples and CCND1 was up-regulated in 7 out of the 12 samples. It is concluded that PI3K/AKT signal pathway is activated in both AML and ALL leukemic cells.
Keywords:PI3K/AKT  AML  ALL  leukemia
本文献已被 CNKI PubMed 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号